Changes

Jump to: navigation, search

Backup

3 bytes added, 13:23, 16 February 2012
/* Methodology */
===Methodology===
# * Step 1: First, list all the players present in Ureteral Stent Market were identified.(The list of companies was retrieved from the FDA site from Registration & Listing database)
**Number of companies that were identified in this step: 20
# * Step 2: The second step involved identifying and eliminating companies that are large, and established players or the subsidiaries of the big players in the industry.
**Number of companies eliminated in this step: 14**Number of (small) companies of interest left: 6
# * Step 3: Once the large, and established players were eliminated, companies were compared based on various parameters and rated on the scale of 5 to identify the best target. Please check the following dashboard:
**Number of potential target companies: 6
# * Step 4: Finally, after an in-depth analysis of the potential target companies’ on various parameters, following companies identified to be best possible target companies. * To improve Product Portfolio : Applied Medical Resources Corp.* To enter in Emerging Markets : Bioteque Corp. 
**To improve Product Portfolio : Applied Medical Resources Corp.
**To enter in Emerging Markets : Bioteque Corp.
===Company Profile===